These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 222889)
1. Antitumor agents. XXXV: Effects of brusatol, bruceoside A, and bruceantin on P-388 lymphocytic leukemia cell respiration. Eigebaly SA; Hall IH; Lee KH; Sumida Y; Imakura Y; Wu RY J Pharm Sci; 1979 Jul; 68(7):887-90. PubMed ID: 222889 [TBL] [Abstract][Full Text] [Related]
2. Antitumor agents. XXXIV: Mechanism of action of bruceoside A and brusatol on nucleic acid metabolism of P-388 lymphocytic leukemia cells. Hall IH; Lee KH; Eigebaly SA; Imakura Y; Sumida Y; Wu RY J Pharm Sci; 1979 Jul; 68(7):883-7. PubMed ID: 458610 [TBL] [Abstract][Full Text] [Related]
3. Antitumor agents XLVI: In vitro effects of esters of brusatol, bisbrusatol, and related compounds on nucleic acid and protein synthesis of P-388 lymphocytic leukemia cells. Hall IH; Liou YF; Okano M; Lee KH J Pharm Sci; 1982 Mar; 71(3):345-8. PubMed ID: 7069596 [TBL] [Abstract][Full Text] [Related]
4. Antitumor agents XLVIII: Structure-activity relationships of quassinoids as in vitro protein synthesis inhibitors of P-388 lymphocytic leukemia tumor cell metabolism. Liou YF; Hall IH; Okano M; Lee KH; Chaney SG J Pharm Sci; 1982 Apr; 71(4):430-5. PubMed ID: 7086652 [TBL] [Abstract][Full Text] [Related]
5. Antitumor agents XLII: Comparison of antileukemic activity of helenalin, brusatol, and bruceantin and their esters on different strains of P-388 lymphocytic leukemic cells. Hall IH; Lee KH; Okano M; Sims D; Ibuka T; Liou YF; Imakura Y J Pharm Sci; 1981 Oct; 70(10):1147-50. PubMed ID: 7299649 [TBL] [Abstract][Full Text] [Related]
6. Antitumor agents XLV: Bisbrusatolyl and brusatolyl esters and related compounds as novel potent antileukemic agents. Lee KH; Okano M; Hall IH; Brent DA; Soltmann B J Pharm Sci; 1982 Mar; 71(3):338-45. PubMed ID: 7069595 [TBL] [Abstract][Full Text] [Related]
7. Antitumor agents XLVII: The effects of bisbrusatolyl malonate on P-388 lymphocytic leukemia cell metabolism. Hall IH; Liou YF; Lee KH; Okano M; Chaney SG J Pharm Sci; 1982 Feb; 71(2):257-62. PubMed ID: 6278124 [TBL] [Abstract][Full Text] [Related]
8. Synthesis of cytotoxic fluorinated quassinoids. Ohno N; Fukamiya N; Okano M; Tagahara K; Lee KH Bioorg Med Chem; 1997 Aug; 5(8):1489-95. PubMed ID: 9313855 [TBL] [Abstract][Full Text] [Related]
9. Antitumor agents LIX: effects of quassinoids on protein synthesis of a number of murine tumors and normal cells. Hall IH; Liou YF; Lee KH; Chaney SG; Willingham W J Pharm Sci; 1983 Jun; 72(6):626-30. PubMed ID: 6875823 [TBL] [Abstract][Full Text] [Related]
10. Anti-inflammatory agents III: Structure-activity relationships of brusatol and related quassinoids. Hall IH; Lee KH; Imakura Y; Okano M; Johnson A J Pharm Sci; 1983 Nov; 72(11):1282-4. PubMed ID: 6417321 [TBL] [Abstract][Full Text] [Related]
11. Antimalarial agents, 4. Synthesis of a brusatol analog and biological activity of brusatol-related compounds. Lee KH; Tani S; Imakura Y J Nat Prod; 1987; 50(5):847-51. PubMed ID: 3325613 [TBL] [Abstract][Full Text] [Related]
12. Antitumor agents XXVII: Effects of helenalin on anaerobic and aerobic metabolism of Ehrlich ascites cells. Hall IH; Lee KH; Eigebaly SA J Pharm Sci; 1978 Apr; 67(4):552-4. PubMed ID: 641768 [TBL] [Abstract][Full Text] [Related]
13. Mechanism of eukaryotic protein synthesis inhibition by brusatol. Willingham W; Stafford EA; Reynolds SH; Chaney SG; Lee KH; Okano M; Hall IH Biochim Biophys Acta; 1981 Jul; 654(2):169-74. PubMed ID: 7284376 [TBL] [Abstract][Full Text] [Related]
14. Yadanzioside P, a new antileukemic quassinoid glycoside from Brucea javanica (L.) Merr with the 3-O-(beta-D-glucopyranosyl)bruceantin structure. Sakaki T; Yoshimura S; Tsuyuki T; Takahashi T; Honda T Chem Pharm Bull (Tokyo); 1986 Oct; 34(10):4447-50. PubMed ID: 3829175 [No Abstract] [Full Text] [Related]
15. Studies on the intracellular localization and effects of 2-chloro-4',+"-di(2-imidazolin-2-yl)terephthalanilide on mitochondria from P388 lymphocytic leukemia and rat liver. Sivak A; Mahoney AJ; Rogers WI Biochem Pharmacol; 1967 Oct; 16(10):1919-31. PubMed ID: 6065957 [No Abstract] [Full Text] [Related]
16. Effects of xanthomegnin and duclauxin on culture cells of murine leukemia and Ehrlich ascitic tumor. Kawai K; Nozawa Y; Ito T; Yamanaka N Res Commun Chem Pathol Pharmacol; 1982 Jun; 36(3):429-38. PubMed ID: 7122988 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic study on bruceoside A revealed the potential role of quassinoid glycosides for the anticancer properties of Fructus Bruceae. Xu Y; Xu M; Zhang L; Zhu Z; Guo S; Su S; Guo J; Che CT; Lin ZX; Zhao M; Duan JA J Pharm Biomed Anal; 2019 Jun; 170():264-272. PubMed ID: 30947127 [TBL] [Abstract][Full Text] [Related]
18. Disposition and metabolism of bruceantin in the mouse. Suling WJ; Woolley CW; Shannon WM Cancer Chemother Pharmacol; 1979; 3(3):171-6. PubMed ID: 527207 [No Abstract] [Full Text] [Related]
19. Comprehensive anti-tumor effect of Brusatol through inhibition of cell viability and promotion of apoptosis caused by autophagy via the PI3K/Akt/mTOR pathway in hepatocellular carcinoma. Ye R; Dai N; He Q; Guo P; Xiang Y; Zhang Q; Hong Z; Zhang Q Biomed Pharmacother; 2018 Sep; 105():962-973. PubMed ID: 30021391 [TBL] [Abstract][Full Text] [Related]
20. Plant antitumor agents. XVI. 6alpha-Senecioyloxy-chaparrinone, a new antileukemic quassinoid from Simaba multiflora. Wani MC; Taylor HL; Thompson JB; Wall ME Lloydia; 1978; 41(6):578-83. PubMed ID: 732540 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]